logo
  

Enzymotec Ltd. (ENZY) Has Fallen To Over A 7-Month Low After Q1 Report

Enzymotec Ltd. (ENZY) reported first quarter non-GAAP EPS of $0.24 Wednesday morning, compared to $0.12 last year. Analysts expected EPS of $0.17. The company now expects full year 2014 non-GAAP EPS of $0.64 to $0.94. The consensus estimate is for EPS of $0.86.

Enzymotec gapped open lower Wednesday and has spiked to the downside in early trade. The stock is currently lower by 4.73 at $15.50 and has plunged to over a 7-month low.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT